These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2993705)

  • 1. [Catecholamine receptors and antagonists: b. Presynaptic receptors].
    Tsuda K; Masuyama Y
    Nihon Rinsho; 1985 May; 43(5):935-42. PubMed ID: 2993705
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ; Cavero I; Massingham R
    Hypertension; 1980; 2(4):372-82. PubMed ID: 6105128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of antihypertensive agents.
    Starke K; Borowski E; Taube HD; Endo T
    Contrib Nephrol; 1977; 8():151-61. PubMed ID: 19198
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interaction of antihypertensive drugs with alpha and beta adrenergic receptors in the central nervous system].
    van Zwieten PA; Timmermans PB
    Actual Pharmacol (Paris); 1980; 32():35-56. PubMed ID: 6244718
    [No Abstract]   [Full Text] [Related]  

  • 5. [Catecholamine receptors and antagonists: a. Post-synaptic receptors].
    Kubo T; Misu Y
    Nihon Rinsho; 1985 May; 43(5):929-34. PubMed ID: 2863403
    [No Abstract]   [Full Text] [Related]  

  • 6. [Presynaptic receptors and their role in regulating neuromediator liberation and in the action of neuropharmacological substances (a review of the literature)].
    Bondarenko TT
    Farmakol Toksikol; 1979; 42(5):559-67. PubMed ID: 39777
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of drugs modifying sympathetic nervous system activity in the treatment of hypertension.
    Peart S
    J Hypertens Suppl; 1985 Dec; 3(4):S51-5. PubMed ID: 3007706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects of hypotensive and anti-angina agents in adrenergic blockade].
    Kazak LI
    Vrach Delo; 1979 Sep; (9):47-9. PubMed ID: 40343
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for alpha adrenergic activation of phosphorylase and inactivation of glycogen synthase in rat adipocytes. Effects of alpha and beta adrenergic agonists and antagonists on glycogen synthase and phosphorylase.
    Lawrence JC; Larner J
    Mol Pharmacol; 1977 Nov; 13(6):1060-75. PubMed ID: 201830
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of neurotransmission through presynaptic receptors and other mechanisms: possible clinical relevance and therapeutic potential.
    Langer SZ; Briley MS; Raisman R
    Adv Biochem Psychopharmacol; 1980; 21():203-12. PubMed ID: 6246739
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha- and beta-receptors.
    Yamaguchi N; de Champlain J; Nadeau RA
    Circ Res; 1977 Jul; 41(1):108-117. PubMed ID: 193655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic alpha- and beta-adrenoceptor stimulation and norepinephrine release in the spontaneously hypertensive rat.
    Ekas RD; Steenberg ML; Woods MS; Lokhandwala MF
    Hypertension; 1983; 5(2):198-204. PubMed ID: 6298101
    [No Abstract]   [Full Text] [Related]  

  • 13. Subsensitivity of the presynaptic alpha adrenoceptors after short-term surgical denervation of the cat nictitating membrane.
    Langer SZ; Luchelli-Fortis MA
    J Pharmacol Exp Ther; 1977 Sep; 202(3):610-21. PubMed ID: 197228
    [No Abstract]   [Full Text] [Related]  

  • 14. Central alpha-adrenergic systems as targets for hypotensive drugs.
    Kobinger
    Rev Physiol Biochem Pharmacol; 1978; 81():39-100. PubMed ID: 25484
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative adrenergic activity in the Long Evans and Sprague Dawley rat].
    Boismare F; Boquet J
    C R Seances Soc Biol Fil; 1979; 173(4):823-7. PubMed ID: 230889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in reactivity of visceral resistive and capacitive vessels during adaptation to high mountain conditions.
    Polenov SA; Chernyavskaya GV; Daniyarov SB; Tkachenko BI
    Hum Physiol; 1978; 4(3):380-4. PubMed ID: 38203
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of alpha-adrenergic responsiveness to clonidine challenge and noradrenergic metabolism in the affective disorders and their treatment.
    Siever LJ; Uhde TW; Silberman EK; Lake CR; Jimerson DC; Risch SC; Kalin NH; Murphy DL
    Psychopharmacol Bull; 1982 Oct; 18(4):118-9. PubMed ID: 6296907
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of the hypotensive effects of medroxalol and its enantiomers, MDL 17,330A and MDL 17,331A.
    Hancock AA
    Clin Exp Hypertens A; 1984; 6(3):659-84. PubMed ID: 6144408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].
    Dausse JP; Guicheney P; Maich PJ; Meyer P
    Nouv Presse Med; 1978 Oct; 7(35):3121-3. PubMed ID: 31601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adrenergic mechanisms in the hypotensive action of a piperazine derivative of 2-aminotetralin].
    Mutafova-Iambolieva V; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1985; 24(1):8-12. PubMed ID: 2992908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.